Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.
about
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritisThe human microbiome: our second genomeRegulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationGlobal Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?The Challenge and Potential of Metagenomics in the ClinicAntibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of ResistancesA Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent ModelsThe Intestinal Microbiota in Inflammatory Bowel DiseaseProbiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspectiveDefining dysbiosis and its influence on host immunity and diseaseThe intestinal microbiota and susceptibility to infection in immunocompromised patientsTowards predictive models of the human gut microbiomeExploring host-microbiota interactions in animal models and humansInnate immune signaling in defense against intestinal microbesPathobionts of the gastrointestinal microbiota and inflammatory diseaseBacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infectionEffector and memory T cell responses to commensal bacteriaEmerging insights on intestinal dysbiosis during bacterial infectionsDistinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniaeSocial interaction, noise and antibiotic-mediated switches in the intestinal microbiotaIntestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantationChemical conversations in the gut microbiotaResurrecting the intestinal microbiota to combat antibiotic-resistant pathogensImpact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC)Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococciImpact of the gut microbiota on rodent models of human diseaseGut microbiota and tacrolimus dosing in kidney transplantationReplenishing our defensive microbesRoutine use of microbial whole genome sequencing in diagnostic and public health microbiologyThe microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasisRoles of the intestinal microbiota in pathogen protection.The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.Fecal Microbiota Transfer for Multidrug-Resistant Gram-Negatives: A Clinical Success Combined With Microbiological FailureImpact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen.Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter.Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations.Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice.The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.
P2860
Q21128781-1D77C070-E6A8-4680-BFAA-A1E51F1E56B6Q24601696-C5D1C662-7A47-4A06-9848-59C8E4DFD1EBQ24626051-0D64D5D3-2597-44D4-B2AD-3281AEE9ED0AQ26745991-247F1162-9E26-411F-A240-01F27F2E5D9BQ26766414-01D05B21-F322-48FD-8E93-DDCF975E6CCCQ26770392-84D654A2-CB57-4B71-BBF7-B0D05DC6CB30Q26795697-25D2A08F-2BCF-4AB3-993B-C74F2C38690EQ26795705-670F3020-0DA3-43D0-8A8C-BE23F5BDDA06Q26850446-4533EBA1-C10B-47E9-A9BF-DC24EF4F466CQ26851835-6AD0CBCF-A730-4253-BED5-9F9FDF760A5EQ26862848-FA2DF925-57AD-4054-94FA-64554B4518A7Q26998253-36A7EE36-414E-40F6-97FD-CFA8D25C04F3Q26999643-995C57B6-21E0-4AFB-9761-4F2E5CAD70BCQ27002611-3388E382-4400-4184-8AFB-EC25B2E2B290Q27008113-8F031943-59A8-4006-AC11-16A780D786F5Q27009228-6F4F76CF-16BC-4791-995F-190783B25A78Q27024742-EC68592E-6C84-4EE6-BB60-C18DFF5B8C4DQ27027423-421F739B-3155-44C4-865E-8C8D1AEABFAFQ27317419-0B464838-C798-4F26-9BBD-338AC22BCAE6Q27331373-FD779FF0-7FA9-4AB9-B3E1-4C4CC9533872Q28067459-3CCC2056-6D69-4DE1-8FDF-FADD3951EC56Q28073357-81E3C6D7-961D-457C-A183-070DB668DE76Q28075653-4C159606-3796-4CD2-817B-620F3E0782A0Q28076453-DCE1587E-810F-43E8-A045-8F9FB411849CQ28085151-EC56F9F8-9307-446F-9939-1FC77B4B288CQ28087215-42A52FDC-2EC9-4A93-8BEA-F575B2FB9B78Q28545131-65589B6C-C79F-4D3D-9526-D9AC8F383CFEQ28655590-50A33BDE-9960-4F37-8269-1866DE71E87FQ28728617-8E0E0D02-1546-46C4-9C8D-8A15B61EA745Q29616351-BFBA47A8-178A-4E69-A33B-54BBD60C8210Q30235535-0A7AA7B6-321E-4006-9B58-1C296C6C151BQ31144277-08704A4E-B860-4F4E-A39A-C5546D481D30Q33575993-0CF35CC0-24E4-4817-A8A7-4B9A4AF1335EQ33609466-59C788F7-C7B8-4D4C-AC93-0FA085B0B541Q33724931-C07F0245-0693-4156-9B13-1C457AEFB74DQ33819284-B8DE0A7E-6BB8-4004-B7F7-E59A9408D044Q33853796-87E08D26-FD16-458D-9DE5-AB957F4AA0B1Q33883909-7C6C7F90-8218-4F6B-9928-CDF1F6795C4DQ33985473-E9A63A4D-B2F8-4267-B609-DB0AE24D9351Q34047880-9DEAC460-5625-4801-A56B-14A7B9CD9DE5
P2860
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@ast
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@en
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@nl
type
label
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@ast
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@en
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@nl
prefLabel
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@ast
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@en
Vancomycin-resistant Enterococ ...... loodstream invasion in humans.
@nl
P2093
P2860
P50
P356
P1476
Vancomycin-resistant Enterococ ...... bloodstream invasion in humans
@en
P2093
Agnes Viale
Eric G Pamer
Marcel R M van den Brink
Michele J Equinda
Miriam Samstein
Nicholas D Socci
Robert R Jenq
P2860
P304
P356
10.1172/JCI43918
P407
P577
2010-11-22T00:00:00Z